Moderna Inc.
Klinger Shannon Thyme Files Moderna (MRNA) Form 4 - November 26, 2025
Transactions
| Insider | Date | Type | Shares | Price | Value | Own |
|---|---|---|---|---|---|---|
| Klinger Shannon Thyme | 2025-11-28 | Sell | 160 | $25.01 | $4.0K | Direct |
| Klinger Shannon Thyme | 2025-11-28 | Buy | 329 | - | $0.00 | Direct |
| Klinger Shannon Thyme | 2025-11-28 | Sell | 329 | $0.00 | $0.00 | Direct |
| Klinger Shannon Thyme | 2025-11-26 | Sell | 773 | $0.00 | $0.00 | Direct |
| Klinger Shannon Thyme | 2025-11-26 | Buy | 773 | - | $0.00 | Direct |
| Klinger Shannon Thyme | 2025-11-26 | Sell | 374 | $24.75 | $9.3K | Direct |
Profitelligence Alerts
Track MRNA insider activity
Get alerts when Moderna Inc. executives trade their shares.
Advertisement
About Moderna Inc.
Moderna Inc. is a biotechnology company focused on developing transformative medicines based on messenger RNA (mRNA) technology. Its primary function is to research and produce a broad spectrum of vaccines and therapeutics by leveraging its proprietary mRNA technology platform. Moderna is notably recognized for its pivotal role in the healthcare and pharmaceutical sector, particularly due to its development of one of the first COVID-19 vaccines to receive emergency use authorization. The company’s pipeline extends beyond infectious diseases, targeting therapeutic areas such as oncology, cardiovascular diseases, and rare genetic disorders. Headquartered in Cambridge, Massachusetts, Moderna takes a leading position in the biotechnology industry through its innovative approach to drug development, emphasizing rapid advancement from concept to clinical application. The company plays a crucial role in addressing global health challenges through its cutting-edge mRNA-based solutions.
Official SEC Documents
Advertisement